Skip to main content

Marshall Wace, LLP

SEC CIK
0001318757
Latest filing
Aug 13, 2026

BIO holding history

Bio-Rad Laboratories, Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BIO overviewAll 13F holders of BIOFull Q2 2026 holdings

Shares (Q2 2026)
18,980
Value
$5.57M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of BIO by Marshall Wace, LLP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202618,980$5.57M<0.1%−14,237−42.9%ReducedHolders
Q1 202633,217$9.26M<0.1%+21,657+187.3%AddedHolders
Q4 202511,560$3.50M<0.1%−1,054−8.4%ReducedHolders
Q3 202512,614$3.54M<0.1%+11,688+1,262.2%AddedHolders
Q2 2025926$223.5K<0.1%−26,169−96.6%ReducedHolders
Q1 202527,095$6.60M<0.1%+24,816+1,088.9%AddedHolders
Q4 20242,279$748.7K<0.1%+2,279NewHolders
Q1 20240$00.0%−6,300−100.0%Sold outHolders
Q4 20236,300$2.03M<0.1%−119,350−95.0%ReducedHolders
Q3 2023125,650$45.0M0.1%+106,037+540.6%AddedHolders
Q2 202319,613$7.44M<0.1%−13,749−41.2%ReducedHolders
Q1 202333,362$16.0M<0.1%+32,767+5,507.1%AddedHolders
Q4 2022595$250.2K<0.1%−172,005−99.7%ReducedHolders
Q3 2022172,600$72.0M0.2%−52,169−23.2%ReducedHolders
Q2 2022224,769$111.3M0.3%−242,574−51.9%ReducedHolders
Q1 2022467,343$263.2M0.5%+133,973+40.2%AddedHolders
Q4 2021333,370$251.9M0.5%−105,974−24.1%ReducedHolders
Q3 2021439,344$327.7M1.6%+4,245+1.0%AddedHolders
Q2 2021435,099$280.3M1.5%−133,819−23.5%ReducedHolders
Q1 2021568,918$324.9M1.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.